--- title: "BAIYUNSHAN PH: Third quarter net profit of 794 million yuan, a year-on-year increase of 30.28%" type: "News" locale: "en" url: "https://longbridge.com/en/news/263047931.md" description: "BAIYUNSHAN PH announced that the revenue for the third quarter was 19.771 billion yuan, a year-on-year increase of 9.74%; the net profit was 794 million yuan, a year-on-year increase of 30.28%. The revenue for the first three quarters was 61.606 billion yuan, a year-on-year increase of 4.31%; the net profit was 3.31 billion yuan, a year-on-year increase of 4.78%" datetime: "2025-10-28T09:37:01.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/263047931.md) - [en](https://longbridge.com/en/news/263047931.md) - [zh-HK](https://longbridge.com/zh-HK/news/263047931.md) --- # BAIYUNSHAN PH: Third quarter net profit of 794 million yuan, a year-on-year increase of 30.28% BAIYUNSHAN PH announced that the revenue for the third quarter was 19.771 billion yuan, a year-on-year increase of 9.74%; the net profit was 794 million yuan, a year-on-year increase of 30.28%. The revenue for the first three quarters was 61.606 billion yuan, a year-on-year increase of 4.31%; the net profit was 3.31 billion yuan, a year-on-year increase of 4.78% ### Related Stocks - [600332.CN](https://longbridge.com/en/quote/600332.CN.md) - [00874.HK](https://longbridge.com/en/quote/00874.HK.md) ## Related News & Research - [Flow Pharma U.S. Patent Application Allowed for Issuance Covering Broad-Spectrum Ebola Therapy](https://longbridge.com/en/news/287076761.md) - [China's Bio-Thera Gets US Nod for Golimumab Biosimilar](https://longbridge.com/en/news/286880573.md) - [Can the business model of operators launching AI token packages be viable?](https://longbridge.com/en/news/286700860.md) - [09:09 ETPacific Mind Health Releases Free Guide to Help People Start Conversations About Mental Health](https://longbridge.com/en/news/287072254.md) - [Funnel earns 2026 NAA Top Employers recognition and ranks No. 11 on Tampa Bay Business Journal’s Best Places to Work list](https://longbridge.com/en/news/287064595.md)